Tuesday, September 27, 2022 | 11 am – 12 pm ET | Virtual

Therapy-related neoplasms are recognized as a late effect of genotoxic exposure (cytotoxic chemotherapy or irradiation as a treatment for primary malignancy) or complication after solid organ transplant or treatment of autoimmune disorder. The importance of recognition of this type of neoplasms in oncology testing will be discussed in this session through a series of representative cases. These illustrative cases will demonstrate the utility of various axillary testing types in identification of markers associated with specific prognosis in this type of cancer and treatment options.

This workshop is for all medical and healthcare professionals and researchers interested in understanding cancer genomic testing and somatic and germline variant interpretation methods. This series is presented as a collaboration between ClinGen Somatic, VICC, and the ACMG consortia.

Learn more and register on the American College of Medical Genetics and Genomics website.